Tumor-Derived Extracellular Vesicles in Cancer–Nerve Crosstalk
- 1Molecular Oncology Laboratory, Medical School, University of Patras, 26504 Patras, Greece
- 2Division of Oncology, Department of Medicine, University Hospital of Patras, 26504 Patras, Greece
Abstract
Communication between tumors and the nervous system influences tumor growth, invasion, pain and immune regulation. This mini-review critically examines extracellular vesicle (EV)-mediated cancer–nerve communication in peripheral solid tumors, selected central nervous system tumors and neuroblastoma. Direct functional evidence is concentrated in a small number of mechanisms and tumor models, with the strongest support for EV-associated neurite outgrowth and tumor innervation in head and neck cancer and more limited supportive evidence in cervical cancer. We organize the evidence by biological process: neurite outgrowth and axon guidance, neuronal reprogramming, microenvironment remodeling and reciprocal neuron–tumor signaling. EV-associated effects on neuronal phenotype, activity, Schwann cells and perineural invasion extend this framework, but do not establish a universal mechanism of EV-driven innervation. Neurite outgrowth, nerve recruitment, neuronal reprogramming and perineural invasion are therefore evaluated as distinct outcomes. Future progress requires tracing tumor-innervating neurons, integrating single-cell and spatial mapping with EV profiling and testing candidate cargo through selective perturbation and rescue. These approaches may identify context-specific therapeutic opportunities, although clinical biomarkers and EV-directed interventions remain investigational.
Related
- Controllable Cascade Aggregation Ion Programmed Nanomachines and Simple Isolation Enable Tumor‐Derived Small Extracellular Vesicles Detection for Enhanced Breast Cancer Assessment
- Natural killer cell-derived extracellular vesicles in cancer: mediators of intercellular communication and tumor immune signaling
- Senescent Cell‐Derived Extracellular Vesicles in Therapy‐Induced Senescence: Immune Remodelling and Emerging Links to Mitochondrial Stress in Cancer
- The Use of TF-Ag-α to Selectively Capture Tumor-Derived Extracellular Vesicles and Enhance the Predictive Performance of Extracellular Vesicle PD-L1 for Response to Immune Checkpoint Inhibitors
- Plant‐Derived Extracellular Vesicles: Biogenesis, Function, and Application in Cancer Immunotherapy
BibTeX
@article{loukopoulou2026tumorderived,
title = {{Tumor-Derived Extracellular Vesicles in Cancer–Nerve Crosstalk}},
author = {Maria Loukopoulou and Anastasia Kottorou and Angelos Koutras and Foteinos-Ioannis Dimitrakopoulos},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210233},
url = {https://www.mdpi.com/1422-0067/27/22/10233},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Tumor-Derived Extracellular Vesicles in Cancer–Nerve Crosstalk
AU - Maria Loukopoulou
AU - Anastasia Kottorou
AU - Angelos Koutras
AU - Foteinos-Ioannis Dimitrakopoulos
PY - 2026
DA - 2026/11/15
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210233
UR - https://www.mdpi.com/1422-0067/27/22/10233
AB - Communication between tumors and the nervous system influences tumor growth, invasion, pain and immune regulation. This mini-review critically examines extracellular vesicle (EV)-mediated cancer–nerve communication in peripheral solid tumors, selected central nervous system tumors and neuroblastoma. Direct functional evidence is concentrated in a small number of mechanisms and tumor models, with the strongest support for EV-associated neurite outgrowth and tumor innervation in head and neck cancer and more limited supportive evidence in cervical cancer. We organize the evidence by biological process: neurite outgrowth and axon guidance, neuronal reprogramming, microenvironment remodeling and reciprocal neuron–tumor signaling. EV-associated effects on neuronal phenotype, activity, Schwann cells and perineural invasion extend this framework, but do not establish a universal mechanism of EV-driven innervation. Neurite outgrowth, nerve recruitment, neuronal reprogramming and perineural invasion are therefore evaluated as distinct outcomes. Future progress requires tracing tumor-innervating neurons, integrating single-cell and spatial mapping with EV profiling and testing candidate cargo through selective perturbation and rescue. These approaches may identify context-specific therapeutic opportunities, although clinical biomarkers and EV-directed interventions remain investigational.
SN - 1422-0067
ER -